| A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer TU Ahearn, A Pettersson, EM Ebot, T Gerke, RE Graff, CL Morais, ... Journal of the National Cancer Institute 108 (2), djv346, 2016 | 213 | 2016 |
| Association of prostate cancer risk variants with gene expression in normal and tumor tissue KL Penney, JA Sinnott, S Tyekucheva, T Gerke, IM Shui, P Kraft, ... Cancer epidemiology, biomarkers & prevention 24 (1), 255-260, 2015 | 158 | 2015 |
| Family history of breast or prostate cancer and prostate cancer risk L Barber, T Gerke, SC Markt, SF Peisch, KM Wilson, T Ahearn, ... Clinical Cancer Research 24 (23), 5910-5917, 2018 | 148 | 2018 |
| Aneuploidy drives lethal progression in prostate cancer KH Stopsack, CA Whittaker, TA Gerke, M Loda, PW Kantoff, LA Mucci, ... Proceedings of the National Academy of Sciences 116 (23), 11390-11395, 2019 | 137 | 2019 |
| A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2) YZ Mazzu, J Armenia, G Chakraborty, Y Yoshikawa, SAA Coggins, ... Clinical Cancer Research 25 (14), 4480-4492, 2019 | 132 | 2019 |
| Cholesterol uptake and regulation in high-grade and lethal prostate cancers KH Stopsack, TA Gerke, O Andrén, SO Andersson, EL Giovannucci, ... Carcinogenesis 38 (8), 806-811, 2017 | 123 | 2017 |
| Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, ... Journal of Clinical Oncology 34 (23), 2705-2711, 2016 | 116 | 2016 |
| Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium IM Shui, S Lindström, AS Kibel, SI Berndt, D Campa, T Gerke, KL Penney, ... European urology 65 (6), 1069-1075, 2014 | 112 | 2014 |
| Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma JV de la Iglesia, RJC Slebos, L Martin-Gomez, X Wang, JK Teer, AC Tan, ... Clinical Cancer Research 26 (6), 1474-1485, 2020 | 94 | 2020 |
| Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation R Brady-Nicholls, JD Nagy, TA Gerke, T Zhang, AZ Wang, J Zhang, ... Nature communications 11 (1), 1750, 2020 | 87 | 2020 |
| Perineural invasion and risk of lethal prostate cancer P Zareba, R Flavin, M Isikbay, JR Rider, TA Gerke, S Finn, A Pettersson, ... Cancer Epidemiology, Biomarkers & Prevention 26 (5), 719-726, 2017 | 85 | 2017 |
| Cholesterol metabolism and prostate cancer lethality KH Stopsack, TA Gerke, JA Sinnott, KL Penney, S Tyekucheva, HD Sesso, ... Cancer research 76 (16), 4785-4790, 2016 | 77 | 2016 |
| Prostate cancer racial disparities: a systematic review by the prostate cancer foundation panel BA Mahal, T Gerke, S Awasthi, HR Soule, JW Simons, A Miyahira, ... European urology oncology 5 (1), 18-29, 2022 | 74 | 2022 |
| ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D K Komura, Y Yoshikawa, T Shimamura, G Chakraborty, TA Gerke, ... The Journal of clinical investigation 128 (7), 2979-2995, 2018 | 70 | 2018 |
| Prognostic utility of a new mRNA expression signature of Gleason score JA Sinnott, SF Peisch, S Tyekucheva, T Gerke, R Lis, JR Rider, ... Clinical Cancer Research 23 (1), 81-87, 2017 | 69 | 2017 |
| MatSurv: Survival analysis and visualization in MATLAB JH Creed, TA Gerke, AE Berglund Journal of Open Source Software 5 (46), 1830, 2020 | 62 | 2020 |
| Circulating vitamin D, vitamin D–related genetic variation, and risk of fatal prostate cancer in the N ational C ancer I nstitute B reast and P rostate C ancer C ohort C onsortium IM Shui, AM Mondul, S Lindström, KK Tsilidis, RC Travis, T Gerke, ... Cancer 121 (12), 1949-1956, 2015 | 62 | 2015 |
| Baseline prostate-specific antigen level in midlife and aggressive prostate cancer in black men MA Preston, T Gerke, SV Carlsson, L Signorello, DD Sjoberg, SC Markt, ... European urology 75 (3), 399-407, 2019 | 60 | 2019 |
| Molecular differences in transition zone and peripheral zone prostate tumors JA Sinnott, JR Rider, J Carlsson, T Gerke, S Tyekucheva, KL Penney, ... Carcinogenesis 36 (6), 632-638, 2015 | 59 | 2015 |
| Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease TU Ahearn, S Peisch, A Pettersson, EM Ebot, CK Zhou, RE Graff, ... Carcinogenesis 39 (12), 1431-1437, 2018 | 53 | 2018 |
Lorelei MucciHarvard TH Chan School of Public HealthVerified email at hsph.harvard.edu
